SEC 13F Intelligence

Highvista Strategies LLC / PRAX

Highvista Strategies LLC’s Praxis Precision Medicines I Position

Does Highvista Strategies LLC own Praxis Precision Medicines I (PRAX)? Yes — 26.3K shares worth $8M (+2.34% of its 13F portfolio) as of Q1 2026, up from 25.8K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
26.3K
% of Portfolio
+2.34%
Quarters Held
7
currently held

Position History PRAX

Reported value by quarter
Q3 ’24: $630,121Q3 ’24Q4 ’24: $842,789Q4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $3MQ2 ’25Q3 ’25: $5MQ3 ’25Q4 ’25: $8MQ4 ’25Q1 ’26: $8MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202626.3K$8M+2.34%
Q4 202525.8K$8M+1.96%
Q3 202595.0K$5M+1.23%
Q2 202567.3K$3M+1.04%
Q1 202539.3K$1M+0.57%
Q4 202411.0K$842,789+0.31%
Q3 202411.0K$630,121+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of PRAX.